Pt. Prodia Stem Cell Indonesia
Clinical trials sponsored by Pt. Prodia Stem Cell Indonesia, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could stem cells be the key to saving lives from Sepsis-Induced lung failure? Results expected Dec 2026 (estimated)
- Can stem cells repair a scarred liver? new trial hopes so Results expected Jun 2027 (estimated)
- Stem cell therapy for rare eye disease passes 5-year safety check Results expected Jul 2027 (estimated)
- Stem cell injection aims to repair kidneys in diabetes patients Results expected Jul 2027 (estimated)
- Could stem cells save sight? new trial tests umbilical cord therapy for eye disease Results expected Jul 2027 (estimated)
-
Stem cell byproduct may boost ACL graft healing — trial puts it to the test
Disease control CompletedThis trial tests whether adding a single injection of MSC-derived secretome — a substance produced by stem cells — during ACL reconstruction surgery can improve knee function and recovery. Twenty-four adults with a complete ACL tear will receive either the secretome or a placebo,…
Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could stem cells help women with PCOS get pregnant?
Disease control CompletedThis study tested whether umbilical cord stem cells and their secretions (secretomes) can help women with polycystic ovary syndrome (PCOS) who also have insulin resistance. 44 women received either stem cells, secretomes, both, or a control treatment. The goal was to see if these…
Phase 1/2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Stem cell treatment shows promise for knee pain relief
Symptom relief CompletedThis study tested a new treatment for knee osteoarthritis using stem cells from umbilical cord tissue. 31 people aged 55-70 with moderate knee arthritis received the stem cells either with or without a minor knee surgery (arthroscopy). The goal was to see if the treatment could r…
Phase 1/2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC